drug
Coronavirus Disease 2019 (COVID-19) vaccine 1
Marketedupdated 5mo agoby $NVAX NOVAVAX INC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6Vaccine component drug with a maximum clinical stage of Approval, with an approval for covid-19.
all catalysts(0)
nothing on the calendar yet
Trials studying Coronavirus Disease 2019 (COVID-19) vaccine 1
- phase2A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
- phase1Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19
- —COVID-19 Vaccines International Pregnancy Exposure Registry
- EP1Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix
- —A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
- phase1A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- phase4Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19
- phase2Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.
News(10)
- Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEOEric Cantor, who represented Virginia in the U.S. House of Representatives for 14 years and served as House majority leader from 2011 to 2014, will step up as PhRMA’s next president and CEO on Nov.…fiercebiotech · 2d ago
- BioNTech to close German manufacturing plants after failing to find buyersTime has run out on BioNTech's bid to locate buyers for sites in Idar-Oberstein, Marburg and Tübingen. Including staff at a Singapore plant also slated for closure, the move could impact 1,860 jobs.biospace · 3d ago
- 6 immunology targets to sustain a mammoth I&I marketJohnson & Johnson, Pfizer, Argenx and more are unlocking new immunology targets and looking to improve on existing ones in an attempt to catch some of the magic brought about by AbbVie’s Humira and…biospace · 6d ago
- Opinion: ClinicalTrials.gov needs a pregnancy and lactation checkboxIt’s hard to identify which clinical trials pregnant and lactating patients can join. Here’s one fix, experts write.stat · 13d ago
- After a brief storm of political headwinds, mRNA is back with strong momentumA year to the day after the Trump administration slashed $500 million in funding from mRNA-based programs, the FDA approved Moderna’s flu vaccine based on the technology. Weeks later, Moderna and M…biospace · 20d ago
- Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?The announcement from Merck & Co. and Moderna last month that their mRNA cancer vaccine had successfully lengthened patient survival in a phase 3 study affirmed the two companies' years of hard wor…fiercebiotech · 1mo ago
- A winner, a loser, and a mid-stage signal from a major cardiology research conferenceThe mental health system after Lindsay Clancy, pushing boundaries for new radiopharmaceuticals, and more health news from Morning Roundsstat · 1mo ago
- Kennedy posts vaccine misinformation, spars on social media amid measles deathsKennedy has blamed others for declining vaccination rates, and downplayed the dangers of measles.stat · 1mo ago
- Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impactAs the dust settles on phase 3 data that added $45 billion to Moderna’s market cap, analysts have begun to ask a question that could define cancer care in the coming years: Can use of the vaccine b…fiercebiotech · 1mo ago
- Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goalMelanoma was slower to recur in patients receiving Merck and Moderna's mRNA vaccine with Keytruda, supporting use of the combination in adjuvant treatment. The partners plan to take the data to the…biospace · 1mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that